← Leaderboards
Stephen G Young
J. David Gladstone Institutes
$51,231,576
Attributed
$52,147,439
Total exposure
27
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$95,590,293 · 30
By mechanism
P01$57,077,378 · 11
R01$16,803,933 · 8
U01$12,993,904 · 2
R35$7,153,739 · 2
RC1$822,395 · 1
S10$461,968 · 5
Top collaborators
- Anne Beigneux4 shared
Most similar at J. David Gladstone Institutes
Same institution · by research overlap
- Steven M Finkbeiner$50,309,699
- Jorge J Palop$21,103,782
- Cheryl Stoddart$14,886,148
- Israel F. Charo$11,507,849
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsLipidsTriglyceride MetabolismEndothelial CellsTissuesAffectPlasmaTriglyceridesCellsResearch PersonnelLipid MetabolismLipolysisReagentLipoprotein LipaseBlood CapillariesMolecularLipoproteinsMutationHypertriglyceridemiaLaboratoriesInsightHeartProgram Research Project GrantsMediating
Grant awards (129)
Regulation of Intravascular Triglyceride Hydrolysis$1,102,500
R35 · FY2025 · HL · contact PI
Investigating Mechanisms for Lipid Transport in Health and Disease$917,279
R35 · FY2024 · HL · contact PI
New approaches for understanding lipid movement in health and disease$2,325,780
P01 · FY2023 · HL · contact PI
Investigating Mechanisms for Lipid Transport in Health and Disease$936,000
R35 · FY2023 · HL · contact PI
Deciphering Mechanisms for Triglyceride and Cholesterol Transport$650,190
P01 · FY2023 · HL · contact PI
Administration$31,200
P01 · FY2023 · HL · contact PI
New approaches for understanding lipid movement in health and disease$2,325,780
P01 · FY2022 · HL · contact PI
Investigating Mechanisms for Lipid Transport in Health and Disease$936,000
R35 · FY2022 · HL · contact PI
Deciphering Mechanisms for Triglyceride and Cholesterol Transport$650,190
P01 · FY2022 · HL · contact PI
Administration$31,200
P01 · FY2022 · HL · contact PI
New approaches for understanding lipid movement in health and disease$2,325,780
P01 · FY2021 · HL · contact PI
Investigating Mechanisms for Lipid Transport in Health and Disease$936,000
R35 · FY2021 · HL · contact PI
Deciphering Mechanisms for Triglyceride and Cholesterol Transport$650,190
P01 · FY2021 · HL · contact PI
Administration$31,200
P01 · FY2021 · HL · contact PI
Understanding the Influence of Lipid Homeostasis on T cell Function$22,590
P01 · FY2021 · HL · contact PI
New approaches for understanding lipid movement in health and disease$2,325,780
P01 · FY2020 · HL · contact PI
Investigating Mechanisms for Lipid Transport in Health and Disease$775,320
R35 · FY2020 · HL · contact PI
Deciphering Mechanisms for Triglyceride and Cholesterol Transport$650,190
P01 · FY2020 · HL · contact PI
A new mechanism for human hypertriglyceridemia and new avenues for investigating intravascular triglyceride metabolism$458,851
R01 · FY2020 · HL · contact PI
Administration$31,200
P01 · FY2020 · HL · contact PI
New approaches for understanding lipid movement in health and disease$2,339,780
P01 · FY2019 · HL · contact PI
Investigating Mechanisms for Lipid Transport in Health and Disease$775,320
R35 · FY2019 · HL · contact PI
Deciphering Mechanisms for Triglyceride and Cholesterol Transport$664,190
P01 · FY2019 · HL · contact PI
A new mechanism for human hypertriglyceridemia and new avenues for investigating intravascular triglyceride metabolism$458,851
R01 · FY2019 · HL · contact PI
Administration$31,200
P01 · FY2019 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$2,309,257
P01 · FY2018 · HL · contact PI
Function of GPIHBP1 in Triglyceride Metabolism$794,547
P01 · FY2018 · HL · contact PI
Investigating Mechanisms for Lipid Transport in Health and Disease$775,320
R35 · FY2018 · HL · contact PI
A new mechanism for human hypertriglyceridemia and new avenues for investigating intravascular triglyceride metabolism$458,116
R01 · FY2018 · HL · contact PI
Administrative Core$59,769
P01 · FY2018 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$2,315,801
P01 · FY2017 · HL · contact PI
Function of GPIHBP1 in Triglyceride Metabolism$794,436
P01 · FY2017 · HL · contact PI
A new mechanism for human hypertriglyceridemia and new avenues for investigating intravascular triglyceride metabolism$455,909
R01 · FY2017 · HL · contact PI
ZMPSTE24, HIV treatment regimens, and atherosclerotic heart disease$440,004
R01 · FY2017 · HL · contact PI
Defining mechanisms for lipid transport across capillary endothelial cells$385,000
R01 · FY2017 · HL · contact PI
Administrative Core$67,812
P01 · FY2017 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$2,312,946
P01 · FY2016 · HL · contact PI
Function of GPIHBP1 in Triglyceride Metabolism$784,642
P01 · FY2016 · HL · contact PI
ZMPSTE24, HIV treatment regimens, and atherosclerotic heart disease$440,004
R01 · FY2016 · HL · contact PI
Defining mechanisms for lipid transport across capillary endothelial cells$385,000
R01 · FY2016 · HL · contact PI
New Insights into Lipoprotein Lipase and Lipolysis$385,000
R01 · FY2016 · HL · contact PI
Administrative Core$60,873
P01 · FY2016 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$2,284,591
P01 · FY2015 · HL · contact PI
Function of GPIHBP1 in Triglyceride Metabolism$786,051
P01 · FY2015 · HL · contact PI
ZMPSTE24, HIV treatment regimens, and atherosclerotic heart disease$433,403
R01 · FY2015 · HL · contact PI
Defining mechanisms for lipid transport across capillary endothelial cells$385,000
R01 · FY2015 · HL · contact PI
New Insights into Lipoprotein Lipase and Lipolysis$379,224
R01 · FY2015 · HL · contact PI
Administrative Core$66,790
P01 · FY2015 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$2,352,632
P01 · FY2014 · HL · contact PI
Function of GPIHBP1 in Triglyceride Metabolism$819,907
P01 · FY2014 · HL · contact PI
ZMPSTE24, HIV treatment regimens, and atherosclerotic heart disease$453,504
R01 · FY2014 · HL · contact PI
New Insights into Lipoprotein Lipase and Lipolysis$377,300
R01 · FY2014 · HL · contact PI
Administrative Core$68,066
P01 · FY2014 · HL · contact PI
CaaX Protein Processing and Human Disease$370,199
R01 · FY2013 · AG · contact PI
New Insights into Lipoprotein Lipase and Lipolysis$366,520
R01 · FY2013 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$2,306,254
P01 · FY2012 · HL · contact PI
Function and Regulation of GPIHBP1 in Lipid Metabolism$461,251
P01 · FY2012 · HL · contact PI
Core B Administration$461,250
P01 · FY2012 · HL · contact PI
CaaX Protein Processing and Human Disease$400,013
R01 · FY2012 · AG · contact PI
New Insights into Lipoprotein Lipase and Lipolysis$398,500
R01 · FY2012 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$2,328,649
P01 · FY2011 · HL · contact PI
Core B Administration$468,127
P01 · FY2011 · HL · contact PI
Function and Regulation of GPIHBP1 in Lipid Metabolism$465,130
P01 · FY2011 · HL · contact PI
CaaX Protein Processing and Human Disease$408,507
R01 · FY2011 · AG · contact PI
GHIHBP1 and the Metabolism of Triglyceride-Rich Lipoproteins$347,250
R01 · FY2011 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$2,371,970
P01 · FY2010 · HL · contact PI
Core B Administration$474,394
P01 · FY2010 · HL · contact PI
Function and Regulation of GPIHBP1 in Lipid Metabolism$474,394
P01 · FY2010 · HL · contact PI
CaaX Protein Processing and Human Disease$421,355
R01 · FY2010 · AG · contact PI
Antibodies to Define Molecular Mechanisms of Hypertriglyceridemia$413,059
RC1 · FY2010 · HL · contact PI
GHIHBP1 and the Metabolism of Triglyceride-Rich Lipoproteins$347,250
R01 · FY2010 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$2,326,432
P01 · FY2009 · HL · contact PI
Core B Administration$472,413
P01 · FY2009 · HL · contact PI
Function and Regulation of GPIHBP1 in Lipid Metabolism$472,412
P01 · FY2009 · HL · contact PI
CaaX Protein Processing and Human Disease$421,963
R01 · FY2009 · AG · contact PI
Antibodies to Define Molecular Mechanisms of Hypertriglyceridemia$409,336
RC1 · FY2009 · HL · contact PI
Hutchinson Gilford Progeria Syndrome and Atherosclerosis$366,235
R01 · FY2009 · HL · contact PI
GHIHBP1 and the Metabolism of Triglyceride-Rich Lipoproteins$347,250
R01 · FY2009 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$17,816
P01 · FY2009 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$17,816
P01 · FY2009 · HL · contact PI
New Molecules in Triglyceride Metabolism and Adipogenesis$2,339,247
P01 · FY2008 · HL · contact PI
Function and Regulation of GPIHBP1 in Lipid Metabolism$818,727
P01 · FY2008 · HL · contact PI
Hutchinson Gilford Progeria Syndrome and Atherosclerosis$366,235
R01 · FY2008 · HL · contact PI
GHIHBP1 and the Metabolism of Triglyceride-Rich Lipoproteins$347,250
R01 · FY2008 · HL · contact PI
Core B Administration$69,290
P01 · FY2008 · HL · contact PI
NHLBI Bay Area Functional Genomics Consortium$1,686,092
U01 · FY2007 · HL · contact PI
Hutchinson Gilford Progeria Syndrome and Atherosclerosis$366,235
R01 · FY2007 · HL · contact PI
GHIHBP1 and the Metabolism of Triglyceride-Rich Lipoproteins$360,500
R01 · FY2007 · HL · contact PI
CAAX Protein Processing and Cancer Therapy$325,949
R01 · FY2007 · CA · contact PI
Postisoprenylation Processing and the Nuclear Lamina$285,116
R01 · FY2007 · AR · contact PI
NHLBI Bay Area Functional Genomics Consortium$1,790,303
U01 · FY2006 · HL · contact PI
Hutchinson Gilford Progeria Syndrome and Atherosclerosis$377,173
R01 · FY2006 · HL · contact PI
CAAX Protein Processing and Cancer Therapy$335,684
R01 · FY2006 · CA · contact PI
Postisoprenylation Processing and the Nuclear Lamina$293,632
R01 · FY2006 · AR · contact PI
NHLBI Bay Area Functional Genomics Consortium$1,778,235
U01 · FY2005 · HL
Postisoprenylation Processing and the Nuclear Lamina$432,902
R01 · FY2005 · AR
Hutchinson Gilford Progeria Syndrome and Atherosclerosis$386,250
R01 · FY2005 · HL
CAAX Protein Processing and Cancer Therapy$287,396
R01 · FY2005 · CA
CAAX Processing Enzymes as Anticancer Targets$138,826
R21 · FY2005 · CA
NHLBI Bay Area Functional Genomics Consortium$1,783,388
U01 · FY2004 · HL
Postisoprenylation Processing and the Nuclear Lamina$428,535
R01 · FY2004 · AR
CAAX Protein Processing and Cancer Therapy$341,908
R01 · FY2004 · CA
JEOL TRANSMISSION ELECTRON MICROSCOPE: NEUROSCIENCE$207,886
S10 · FY2004 · RR
JEOL TRANSMISSION ELECTRON MICROSCOPE: CELL BIOLOGY$138,590
S10 · FY2004 · RR
CAAX Processing Enzymes as Anticancer Targets$138,150
R21 · FY2004 · CA
JEOL TRANSMISSION ELECTRON MICROSCOPE: AIDS$69,295
S10 · FY2004 · RR
CAAX Protein Processing and Cancer Therapy$56,367
R01 · FY2004 · CA
JEOL TRANSMISSION ELECTRON MICROSCOPE: CARDIOVASCULAR$23,099
S10 · FY2004 · RR
JEOL TRANSMISSION ELECTRON MICROSCOPE: LIVER$23,098
S10 · FY2004 · RR
LIPOPROTEIN STRUCTURE/FUNCTION IN CHOLESTEROL METABOLISM$2,234,307
P01 · FY2003 · HL
THE NHLBI BAY AREA FUNCTIONAL GENOMICS CONSORTIUM$1,395,347
U01 · FY2003 · HL
THE NHLBI BAY AREA FUNCTIONAL GENOMICS COMSORTIUM$528,547
U01 · FY2003 · HL
CAAX Protein Processing and Cancer Therapy$398,275
R01 · FY2003 · CA
Postisoprenylation Processing and the Nuclear Lamina$378,585
R01 · FY2003 · AR
LIPOPROTEIN STRUCTURE/FUNCTION IN CHOLESTEROL METABOLISM$2,163,055
P01 · FY2002 · HL
THE NHLBI BAY AREA FUNCTIONAL GENOMICS CONSORTIUM$1,278,152
U01 · FY2002 · HL
METABOLISM OF SPONTANEOUSLY DAMAGED PROTEINS IN AGING$323,291
R01 · FY2002 · AG
THE NHLBI BAY AREA FUNCTIONAL GENOMICS COMSORTIUM$262,457
U01 · FY2002 · HL
CORE--ANIMAL MODEL$239,204
P01 · FY2002 · HL
LIPOPROTEIN STRUCTURE/FUNCTION IN CHOLESTEROL METABOLISM$2,075,084
P01 · FY2001 · HL
THE NHLBI BAY AREA FUNCTIONAL GENOMICS CONSORTIUM$1,269,731
U01 · FY2001 · HL
METABOLISM OF SPONTANEOUSLY DAMAGED PROTEINS IN AGING$315,165
R01 · FY2001 · AG
NEW MODELS FOR STUDYING APOLIPOPROTEIN B METABOLISM$243,516
P01 · FY2001 · HL
CORE--ANIMAL MODEL$239,204
P01 · FY2001 · HL
LIPOPROTEIN STRUCTURE/FUNCTION IN CHOLESTEROL METABOLISM$2,021,507
P01 · FY2000 · HL
THE NHLBI BAY AREA FUNCTIONAL GENOMICS CONSORTIUM$1,221,652
U01 · FY2000 · HL
METABOLISM OF SPONTANEOUSLY DAMAGED PROTEINS IN AGING$307,277
R01 · FY2000 · AG
CORE--ANIMAL MODEL$285,313
P01 · FY2000 · HL
NEW MODELS FOR STUDYING APOLIPOPROTEIN B METABOLISM$266,056
P01 · FY2000 · HL